These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18620950)

  • 1. Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial.
    Clarke SE; Jukes MC; Njagi JK; Khasakhala L; Cundill B; Otido J; Crudder C; Estambale BB; Brooker S
    Lancet; 2008 Jul; 372(9633):127-138. PubMed ID: 18620950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial.
    Glinz D; Hurrell RF; Ouattara M; Zimmermann MB; Brittenham GM; Adiossan LG; Righetti AA; Seifert B; Diakité VG; Utzinger J; N'Goran EK; Wegmüller R
    Malar J; 2015 Sep; 14():347. PubMed ID: 26377199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
    Konaté AT; Yaro JB; Ouédraogo AZ; Diarra A; Gansané A; Soulama I; Kangoyé DT; Kaboré Y; Ouédraogo E; Ouédraogo A; Tiono AB; Ouédraogo IN; Chandramohan D; Cousens S; Milligan PJ; Sirima SB; Greenwood BM; Diallo DA
    PLoS One; 2011; 6(8):e23391. PubMed ID: 21858097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Cameroon.
    Martinez-Vega R; Mbacham WF; Ali I; Nji A; Mousa A; Beshir KB; Chopo-Pizarro A; Kaur H; Okell L; Hansson H; Hocke EF; Alifrangis M; Gosling R; Roper C; Sutherland C; Chico RM
    BMC Infect Dis; 2024 Sep; 24(1):1028. PubMed ID: 39327613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
    Aponte JJ; Schellenberg D; Egan A; Breckenridge A; Carneiro I; Critchley J; Danquah I; Dodoo A; Kobbe R; Lell B; May J; Premji Z; Sanz S; Sevene E; Soulaymani-Becheikh R; Winstanley P; Adjei S; Anemana S; Chandramohan D; Issifou S; Mockenhaupt F; Owusu-Agyei S; Greenwood B; Grobusch MP; Kremsner PG; Macete E; Mshinda H; Newman RD; Slutsker L; Tanner M; Alonso P; Menendez C
    Lancet; 2009 Oct; 374(9700):1533-42. PubMed ID: 19765816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
    Shulman CE; Dorman EK; Cutts F; Kawuondo K; Bulmer JN; Peshu N; Marsh K
    Lancet; 1999 Feb; 353(9153):632-6. PubMed ID: 10030329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.
    Dorsey G; Njama D; Kamya MR; Cattamanchi A; Kyabayinze D; Staedke SG; Gasasira A; Rosenthal PJ
    Lancet; 2002 Dec 21-28; 360(9350):2031-8. PubMed ID: 12504399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
    Dicko A; Barry A; Dicko M; Diallo AI; Tembine I; Dicko Y; Dara N; Sidibe Y; Santara G; Conaré T; Chandramohan D; Cousens S; Milligan PJ; Diallo DA; Doumbo OK; Greenwood B
    PLoS One; 2011; 6(8):e23390. PubMed ID: 21858096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.
    Tine RC; Faye B; Ndour CT; Ndiaye JL; Ndiaye M; Bassene C; Magnussen P; Bygbjerg IC; Sylla K; Ndour JD; Gaye O
    Malar J; 2011 Dec; 10():358. PubMed ID: 22166001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
    Dicko A; Roh ME; Diawara H; Mahamar A; Soumare HM; Lanke K; Bradley J; Sanogo K; Kone DT; Diarra K; Keita S; Issiaka D; Traore SF; McCulloch C; Stone WJR; Hwang J; Müller O; Brown JM; Srinivasan V; Drakeley C; Gosling R; Chen I; Bousema T
    Lancet Infect Dis; 2018 Jun; 18(6):627-639. PubMed ID: 29422384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influences of intermittent preventive treatment and persistent multiclonal Plasmodium falciparum infections on clinical malaria risk.
    Liljander A; Chandramohan D; Kweku M; Olsson D; Montgomery SM; Greenwood B; Färnert A
    PLoS One; 2010 Oct; 5(10):e13649. PubMed ID: 21048970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial.
    Cissé B; Sokhna C; Boulanger D; Milet J; Bâ el H; Richardson K; Hallett R; Sutherland C; Simondon K; Simondon F; Alexander N; Gaye O; Targett G; Lines J; Greenwood B; Trape JF
    Lancet; 2006 Feb; 367(9511):659-67. PubMed ID: 16503464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial.
    Halliday KE; Okello G; Turner EL; Njagi K; Mcharo C; Kengo J; Allen E; Dubeck MM; Jukes MC; Brooker SJ
    PLoS Med; 2014 Jan; 11(1):e1001594. PubMed ID: 24492859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial.
    Staedke SG; Kamya MR; Dorsey G; Gasasira A; Ndeezi G; Charlebois ED; Rosenthal PJ
    Lancet; 2001 Aug; 358(9279):368-74. PubMed ID: 11502317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial.
    Kweku M; Liu D; Adjuik M; Binka F; Seidu M; Greenwood B; Chandramohan D
    PLoS One; 2008; 3(12):e4000. PubMed ID: 19098989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent preventive treatment of malaria delivered to primary schoolchildren provided effective individual protection in Jinja, Uganda: secondary outcomes of a cluster-randomized trial (START-IPT).
    Rehman AM; Maiteki-Sebuguzi C; Gonahasa S; Okiring J; Kigozi SP; Chandler CIR; Drakeley C; Dorsey G; Kamya MR; Staedke SG
    Malar J; 2019 Sep; 18(1):318. PubMed ID: 31533845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
    Kajubi R; Ochieng T; Kakuru A; Jagannathan P; Nakalembe M; Ruel T; Opira B; Ochokoru H; Ategeka J; Nayebare P; Clark TD; Havlir DV; Kamya MR; Dorsey G
    Lancet; 2019 Apr; 393(10179):1428-1439. PubMed ID: 30910321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.
    Mutabingwa TK; Anthony D; Heller A; Hallett R; Ahmed J; Drakeley C; Greenwood BM; Whitty CJ
    Lancet; 2005 Apr 23-29; 365(9469):1474-80. PubMed ID: 15850631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.